To do so, we used a bioinformatics approach by analysing data from The Cancer Genome Atlas (TCGA) database.21 The results from this analysis revealed that a wide landscape of TP53 mutations exists in HNSCC and, for the first time, demonstrated that these mutations are associated with distinct clinical behaviour in a site-specific manner. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.